•  
  •  
  •  
  •  

2025-10-02 07:54:58

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  3Observations

Stock Report

  • Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility
  • Dr. Reddy's Laboratories Ltd gets 3 observations from USFDA for R&D Centre
  • Alkem Laboratories Ltd receives 3 observations from USFDA for API manufacturing facility located at Mandva
  • Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village
  • Neuland Laboratories Limited updates on USFDA inspection
  • Hikal announces US FDA Audit with Zero Observations
  • Ipca Laboratories Limited gets 3 observations for Piparia, Silvassa unit
  • Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility
  • Granules India Ltd gets 3 observations from USFDA for Gagillapur facility
  • Strides announces successful completion of US FDA inspection at its Singapore facility
  • USFDA issues 3 observations for Aurobindo Pharma Ltd's Unit XI
  • Biocon gets 3 observations from US FDA for Site 3 at Hyderabad
  • US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024